5. Barros JA, Filippin-Monteiro FB, de Oliveira EM, et al. Cytotoxicity of PVPAC-treated bovine pericardium:a potential replacement for glutaraldehyde in biological heart valves. J Biomed Mater Res B Appl Biomater, 2014, 102(3):574-582.
16. Brizard CP, Brink J, Horton SB, et al. New engineering treatment of bovine pericardium confers outstanding resistance to calcification in mitral and pulmonary implantations in a juvenile sheep model. J Thorac Cardiovasc Surg, 2014, 148(6):3194-3201.
1. Strange G, Brizard C, Karl TR, et al. An evaluation of Admedus' tissue engineering process-treated (ADAPT) bovine pericardium patch (CardioCel) for the repair of cardiac and vascular defects. Expert Rev Med Devices, 2015, 12(2):135-141.
[10]
2. Dorweiler B, Kayser C, Zipp F, et al. Long-term performance of the bovine pericardium patch in conventional carotid endarterectomy. Thorac Cardiovasc Surg, 2015, 63(2):168-174.
[11]
3. Gubitosi A, Docimo G, Parmeggiani D, et al. Acellular bovine pericardium dermal matrix in immediate breast reconstruction after Skin Sparing Mastectomy. Int J Surg, 2014, 12 Suppl 1:S205-208.
[12]
4. Leon-Takahashi AM, Gomez-Pedraza A, Cruz-Rodriguez A, et al. Use of glutaraldehyde-preserved bovine pericardium patch in vascular repair of portal vein in a patient with pancreatic cancer. Indian J Surg, 2013, 75(Suppl 1):247-249.
[13]
6. Shepherd DV, Shepherd JH, Ghose S, et al. The process of EDCNHS cross-linking of reconstituted collagen fibres increases collagen fibrillar order and alignment. APL Mater, 2015, 3(1):014902.
8. Maizato MJ, Higa OZ, Mathor MB, et al. Glutaraldehyde-treated bovine pericardium:effects of lyophilization on cytotoxicity and residual aldehydes. Artif Organs, 2003, 27(8):692-694.
[16]
9. Chang Y, Tsai CC, Liang HC, et al. In vivo evaluation of cellular and acellular bovine pericardia fixed with a naturally occurring crosslinking agent (genipin). Biomaterials, 2002, 23(12):2447-2457.
21. Gratzer PF, Lee JM. Control of pH alters the type of cross-linking produced by 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) treatment of acellular matrix vascular grafts. J Biomed Mater Res, 2001, 58(2):172-179.
